Business Context and Reporting Period
Company: The Coca-Cola Company (KO)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 27, 2025 (Second Quarter)
Reporting Status: Large Accelerated Filer
The Company reported strong profitability in Q2 2025, driven by favorable pricing initiatives and significantly lower "other operating charges" compared to the prior year. The period included the final milestone payment for the fairlife acquisition and continued refranchising activities in India.
Key Financial Metrics (Six Months Ended June 27, 2025)
| Metric | 2025 (YTD) | 2024 (YTD) | Change |
|---|---|---|---|
| Net Operating Revenues | $23,664 million | $23,663 million | Flat (+$1M) |
| Gross Profit | $14,787 million | $14,616 million | +$171 million |
| Gross Margin | 62.5% | 61.8% | +70 bps |
| Operating Income | $7,939 million | $4,773 million | +$3,166 million (+66%) |
| Operating Margin | 33.6% | 20.2% | +1,340 bps |
| Net Income (Attributable to Shareowners) | $7,140 million | $5,588 million | +$1,552 million (+28%) |
| Diluted EPS | $1.65 | $1.29 | +$0.36 |
| Cash from Operations | ($1,391 million) | $4,113 million | ($5,504 million) |
| Free Cash Flow (Approx.) | ($2,142 million) | $3,321 million | N/A |
| Total Debt (Current + Long-term) | $49,446 million | $43,874 million | +$5,572 million |
| Cash & Equivalents | $9,590 million | $13,708 million | ($4,118 million) |
Note: Free Cash Flow calculated as Operating Cash Flow less Capital Expenditures ($751M).
Material Changes vs. Prior Period
- Operating Income Surge: Operating income increased 66% year-over-year. This was primarily due to a reduction in "Other Operating Charges" from $2,943 million in 2024 to $144 million in 2025. The 2024 period included a $2,102 million remeasurement of contingent consideration for fairlife and a $760 million impairment of the BodyArmor trademark, neither of which occurred in 2025.
- Revenue Stability: Net operating revenues remained flat ($23.66 billion) despite a 5% favorable impact from price, product, and geographic mix. This was offset by a 4% negative impact from foreign currency fluctuations (stronger U.S. dollar) and a 1% negative impact from acquisitions and divestitures.
- Cash Flow Volatility: Operating cash flow turned negative ($1.39 billion outflow) compared to a $4.1 billion inflow in the prior year. The primary driver was the $6.07 billion final milestone payment for the fairlife acquisition made in March 2025.
- Volume Trends: Worldwide unit case volume increased 1% for the six months ended June 27, 2025. Europe, Middle East & Africa grew 3%, while North America declined 2% and Asia Pacific grew 1%.
Guidance, Outlook, and Risks
- Effective Tax Rate: Management expects the full-year 2025 effective tax rate to be approximately 20.8%, excluding the potential impact of significant operating/nonoperating items or the outcome of ongoing tax litigation.
- Capital Allocation: Priorities include investing in operations, growing dividends, and share repurchases to offset dilution. 2025 capital expenditures are expected to be approximately $2.2 billion.
- Foreign Exchange: Based on current spot rates and hedging, the Company expects foreign currency fluctuations to have an unfavorable impact on full-year 2025 operating income and cash flows.
- IRS Tax Litigation (Critical Risk):
- The Company is in litigation with the IRS regarding transfer pricing for tax years 2007–2009. The Tax Court ruled against the Company, resulting in a $6.0 billion liability (including interest) which the Company paid in September 2024 as a deposit pending appeal.
- The Company has appealed to the U.S. Court of Appeals for the Eleventh Circuit and believes it is "more likely than not" to prevail.
- Contingency: If the Company does not prevail, it estimates a potential aggregate remaining incremental tax and interest liability for tax years 2010–2024 of approximately $12 billion. Continued application of the Tax Court methodology in 2025 could increase the effective tax rate by approximately 3.5%.
- Other Legal: An environmental lawsuit in Baltimore regarding plastic packaging had most claims dismissed, with proceedings on a public nuisance claim stayed pending Maryland Supreme Court rulings.
Investor Verification Checklist
- IRS Litigation Status: Monitor the appeal process in the U.S. Court of Appeals for the Eleventh Circuit regarding the $6.0 billion tax deposit and the potential $12 billion exposure for subsequent years.
- Cash Flow Recovery: Verify the normalization of operating cash flows in subsequent quarters following the one-time $6.1 billion fairlife payment.
- Foreign Currency Impact: Track the U.S. dollar strength against key currencies (Mexican peso, Brazilian real, Argentine peso) as this continues to negatively impact reported revenues and operating income.
- BodyArmor Valuation: Review future impairment testing for the BodyArmor trademark, which had a $760 million impairment in 2024; management noted fair value approximates carrying value as of June 2025 but remains sensitive to operating results and discount rates.
- Refranchising Execution: Monitor the impact of ongoing bottling refranchising in India and other territories on the "Bottling Investments" segment revenue and volume.